Optimal Patient Adherence and Long-Term Treatment Outcomes of Neovascular Age-Related Macular Degeneration in Real-Life
Author:
Affiliation:
1. Department of Ophthalmology, Ludwig-Maximilians-University of Munich, Munich, Germany
2. Department of Ophthalmology, University Hospital Ulm, Ulm, Germany
3. Munich Eye & Vascular Medicine Center, Munich, Germany
Publisher
Informa UK Limited
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Link
https://www.tandfonline.com/doi/pdf/10.1080/02713683.2022.2044056
Reference26 articles.
1. The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
2. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
3. Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration
4. LONG-TERM FOLLOW-UP FOR TYPE 1 (SUBRETINAL PIGMENT EPITHELIUM) NEOVASCULARIZATION USING A MODIFIED “TREAT AND EXTEND” DOSING REGIMEN OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
5. COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term results of treatment of neovascular age-related macular degeneration using antiangiogenic drugs: A review of the literature;Archivos de la Sociedad Española de Oftalmología (English Edition);2024-05
2. Resultados a largo plazo del tratamiento de la degeneración macular asociada a la edad neovascular mediante fármacos antiangiogénicos: revisión de la bibliografía;Archivos de la Sociedad Española de Oftalmología;2023-12
3. Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration;Pharmaceutics;2023-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3